Abstract
Mitochondrial diseases are a clinically heterogeneous group of multisystemic disorders that arise as a result of various mitochondrial dysfunctions. Autosomal recessive aARS deficiencies represent a rapidly growing group of severe rare inherited mitochondrial diseases, involving multiple organs, and currently without curative option. They might be related to defects of mitochondrial aminoacyl t-RNA synthetases (mtARS) that are ubiquitous enzymes involved in mitochondrial aminoacylation and the translation process. Here, using NGS analysis of 281 nuclear genes encoding mitochondrial proteins, we identified 4 variants in different mtARS in three patients from unrelated Tunisian families, with clinical features of mitochondrial disorders. Two homozygous variants were found in KARS (c.683C>T) and AARS2 (c.1150-4C>G), respectively in two patients, while two heterozygous variants in EARS2 (c.486-7C>G) and DARS2 (c.1456C>T) were concomitantly found in the third patient. Bio-informatics investigations predicted their pathogenicity and deleterious effects on pre-mRNA splicing and on protein stability. Thus, our results suggest that mtARS mutations are common in Tunisian patients with mitochondrial diseases.
Similar content being viewed by others
References
Thorburn DR, Sugiana C, Salemi R et al (2004) Biochemical and molecular diagnosis of mitochondrial respiratory chain disorders. Biochim Biophys Acta Bioenergetics. https://doi.org/10.1016/j.bbabio.2004.08.006
Davis RL, Liang C, Sue CM (2018) Mitochondrial diseases. In: Handbook of clinical neurology
El-Hattab AW, Scaglia F (2016) Mitochondrial cytopathies. Cell Calcium 60:199–206
Musier-Forsyth K (2019) Aminoacyl-tRNA synthetases and tRNAs in human disease: an introduction to the JBC reviews thematic series. J Biol Chem. https://doi.org/10.1074/jbc.REV119.007721
Diodato D, Ghezzi D, Tiranti V (2014) The mitochondrial aminoacyl tRNA synthetases: genes and syndromes. Int J Cell Biol. https://doi.org/10.1155/2014/787956
Sissler M, González-Serrano LE, Westhof E (2017) Recent Advances in Mitochondrial Aminoacyl-tRNA Synthetases and Disease. Trends Mol Med. https://doi.org/10.1016/j.molmed.2017.06.002
Tolkunova E, Park H, Xia J et al (2000) The human lysyl-tRNA synthetase gene encodes both the cytoplasmic and mitochondrial enzymes by means of an unusual: alternative splicing of the primary transcript. J Biol Chem. https://doi.org/10.1074/jbc.M006265200
Antonellis A, Green ED (2008) The role of aminoacyl-tRNA synthetases in genetic diseases. Annu Rev Genom Hum Genet. https://doi.org/10.1146/annurev.genom.9.081307.164204
Taylor RW, Pyle A, Griffin H et al (2014) Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. JAMA. https://doi.org/10.1001/jama.2014.7184
González-Serrano LE, Chihade JW, Sissler M (2019) When a common biological role does not imply common disease outcomes: Disparate pathology linked to human mitochondrial aminoacyl-tRNA synthetases. J Biol Chem. https://doi.org/10.1074/jbc.REV118.002953
Moulinier L, Ripp R, Castillo G et al (2017) MiSynPat: an integrated knowledge base linking clinical, genetic, and structural data for disease-causing mutations in human mitochondrial aminoacyl-tRNA synthetases. Hum Mutat. https://doi.org/10.1002/humu.23277
Srivastava S, Butala A, Mahida S et al (2019) Expansion of the clinical spectrum associated with AARS2-related disorders. Am J Med Genet Part A. https://doi.org/10.1002/ajmg.a.61188
Lewin HA (1992) A simple method for DNA extraction from leukocytes for use in PCR. Biotechniques 13:522–524
Felhi R, Sfaihi L, Charif M et al (2019) Next generation sequencing in family with MNGIE syndrome associated to optic atrophy: Novel homozygous POLG mutation in the C-terminal sub-domain leading to mtDNA depletion. Clin Chim Acta. https://doi.org/10.1016/j.cca.2018.11.003
Källberg M, Margaryan G, Wang S et al (2014) Raptorx server: A resource for template-based protein structure modeling. Methods Mol Biol. https://doi.org/10.1007/978-1-4939-0366-5_2
Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. https://doi.org/10.1002/elps.1150181505
Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. https://doi.org/10.1093/nar/gkg595
Ruzzenente B, Assouline Z, Barcia G et al (2018) Inhibition of mitochondrial translation in fibroblasts from a patient expressing the KARS p.(Pro228Leu) variant and presenting with sensorineural deafness, developmental delay, and lactic acidosis. Hum Mutat. https://doi.org/10.1002/humu.23657
Lieber DS, Calvo SE, Shanahan K et al (2013) Targeted exome sequencing of suspected mitochondrial disorders. Neurology. https://doi.org/10.1212/WNL.0b013e3182918c40
Scheidecker S, Bär S, Stoetzel C et al (2019) Mutations in KARS cause a severe neurological and neurosensory disease with optic neuropathy. Hum Mutat. https://doi.org/10.1002/humu.23799
Fuchs SA, Schene IF, Kok G et al (2019) Aminoacyl-tRNA synthetase deficiencies in search of common themes. Genet Med. https://doi.org/10.1038/s41436-018-0048-y
Zhou XL, He LX, Yu LJ et al (2017) Mutations in KARS cause early-onset hearing loss and leukoencephalopathy: potential pathogenic mechanism. Hum Mutat. https://doi.org/10.1002/humu.23335
Verrigni D, Diodato D, Di Nottia M et al (2017) Novel mutations in KARS cause hypertrophic cardiomyopathy and combined mitochondrial respiratory chain defect. Clin Genet. https://doi.org/10.1111/cge.12931
Ardissone A, Tonduti D, Legati A et al (2018) KARS-related diseases: progressive leukoencephalopathy with brainstem and spinal cord calcifications as new phenotype and a review of literature. Orphanet J Rare Dis. https://doi.org/10.1186/s13023-018-0788-4
Casey JP, Slattery S, Cotter M et al (2015) Clinical and genetic characterisation of infantile liver failure syndrome type 1, due to recessive mutations in LARS. J Inherit Metab Dis. https://doi.org/10.1007/s10545-015-9849-1
Warf MB, Berglund JA (2010) Role of RNA structure in regulating pre-mRNA splicing. Trends Biochem Sci. https://doi.org/10.1016/j.tibs.2009.10.004
Götz A, Tyynismaa H, Euro L et al (2011) Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. Am J Hum Genet. https://doi.org/10.1016/j.ajhg.2011.04.006
Dallabona C, Diodato D, Kevelam SH et al (2014) Novel (ovario) leukodystrophy related to AARS2 mutations. Neurology. https://doi.org/10.1212/WNL.0000000000000497
Taglia I, Di Donato I, Bianchi S et al (2018) AARS2-related ovarioleukodystrophy: Clinical and neuroimaging features of three new cases. Acta Neurol Scand. https://doi.org/10.1111/ane.12954
Tang Y, Qin Q, Xing Y et al (2019) AARS2 leukoencephalopathy: A new variant of mitochondrial encephalomyopathy. Mol Genet Genom Med. https://doi.org/10.1002/mgg3.582
Lynch DS, Paiva RBDA, Zhang WJ et al (2017) Clinical and genetic characterization of leukoencephalopathies in adults. Brain. https://doi.org/10.1093/brain/awx045
Steenweg ME, Ghezzi D, Haack T et al (2012) Leukoencephalopathy with thalamus and brainstem involvement and high lactate “LTBL” caused by EARS2 mutations. Brain. https://doi.org/10.1093/brain/aws070
Oliveira R, Sommerville EW, Thompson K et al (2017) Lethal neonatal LTBL associated with biallelic ears2 variants: case report and review of the reported neuroradiological features. In: JIMD Reports
Yelam A, Nagarajan E, Chuquilin M, Govindarajan R (2019) Leucoencephalopathy with brain stem and spinal cord involvement and lactate elevation: a novel mutation in the DARS2 gene. BMJ Case Rep. https://doi.org/10.1136/bcr-2018-227755
Acknowledgements
We would like to thank all the member of the family for their cooperationin the present study. This work was supported by the Ministryof Higher Education and Scientific Research in Tunisia, University of Sfax.Weacknowledge the support from the National Institute of Health and Medical Research (INSERM), Centre National de la Recherche Scientifique (CNRS), the Université d’Angers, the UniversityHospital of Angers, the Région Pays de Loire and Angers Loire Métropole.
Funding
There is no funding source.
Author information
Authors and Affiliations
Contributions
Felhi, Charif, Fakhfakh and Lenaers had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Clinical investigation and phenotyping: Lamia sfaihi, Rim Kalleland Mongia Hachicha. Analysis or interpretation of data: Felhi, Charif, Emna mkaouer-Rebai, Desquiret-Dumas, Bris, Goudenège, Guichet, Lenaers and Fakhfakh. Draft of the manuscript: Felhi, Charif, Sfaihi, Fakhfakh and Lenaers. Critical revision of the manuscript for important intellectual content: Bonneau, Procaccio, Reynier, Amati-Bonneau, Lenaers and Fakhfakh.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study was conducted in accordance with the principles stated in the Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects, Helsinki, Finland, 1964, and as amended in Fortaleza, Brazil, 2013. The study design was approved by the committee on research ethics of the University of Sfax, Tunisia.
Informed consent
All participants provided written informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Felhi, R., Charif, M., Sfaihi, L. et al. Mutations in aARS genes revealed by targeted next-generation sequencing in patients with mitochondrial diseases. Mol Biol Rep 47, 3779–3787 (2020). https://doi.org/10.1007/s11033-020-05425-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-020-05425-3